A case of severe erythema nodosum induced by methimazole  by Emre, Selma et al.
Saudi Pharmaceutical Journal (2016) xxx, xxx–xxxKing Saud University
Saudi Pharmaceutical Journal
www.ksu.edu.sa
www.sciencedirect.comCASE REPORTA case of severe erythema nodosum induced by
methimazole* Corresponding author at: Yildirim Beyazit University, Ataturk
Training and Research Hospital, Dermatology Clinic, Bilkent,
Ankara, Turkey. Fax: +90 312 2912705.
E-mail address: dr_semre@yahoo.com (S. Emre).
Peer review under responsibility of King Saud University.
Production and hosting by Elsevier
http://dx.doi.org/10.1016/j.jsps.2016.11.003
1319-0164  2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Please cite this article in press as: Emre, S. et al., A case of severe erythema nodosum induced by methimazole. Saudi Pharmaceutical Journal (2016), http://dx
10.1016/j.jsps.2016.11.003Selma Emre a,*, Didem Ozdemir b, Sibel Orhun c, Goknur Kalkan a, Sertac Sener aaYildirim Beyazit University, Ataturk Training and Research Hospital, Dermatology Clinic, Ankara, Turkey
bYildirim Beyazit University, Ataturk Training and Research Hospital, Endocrinology Clinic, Ankara, Turkey
cYildirim Beyazit University, Ataturk Training and Research Hospital, Pathology Department, Ankara, TurkeyReceived 3 January 2016; accepted 5 November 2016KEYWORDS
Anti-thyroid drugs;
Erythema nodosum;
MethimazoleAbstract Erythema nodosum (EN), is the most common variant of septal panniculitis and is pos-
sibly a delayed hypersensitivity reaction triggered by a wide range of antigenic stimuli. Hypersen-
sitivity reactions due to medications have been recognized as a cause of 3–10% of EN cases.
Case reports of EN associated with the anti-thyroid drugs are quite rarely reported in the literature
even if there is a common use of anti-thyroid drugs. We report an EN case due to methimazole. The
complaints of patients arose immediately fifteen days after the beginning of methimazole treatment.
To the best of our knowledge, this case report is the first of an erythema nodosum induced by
methimazole.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Erythema nodosum (EN), is the most common variant of sep-
tal panniculitis. Cutaneous lesions are usually acute, painful,
erythematous, round or oval subcutaneous nodules on the
extensor areas of the lower extremities. EN is possibly a
delayed hypersensitivity reaction triggered by a wide range of
antigenic stimuli. The most common causes include drugs,bacterial, viral and fungal infections, pregnancy, systemic dis-
eases such as sarcoidosis, malignant diseases, and inflamma-
tory bowel diseases. However, in more than 55% cases
etiologic factors cannot be cleared and are considered to be
idiopathic. Hypersensitivity reactions due to medications have
been recognized as a cause of 3–10% of EN cases (Blake et al.,
2014; Schwartz and Nervi, 2007). We report an EN case due to
methimazole, as an unusual cause. To the best of our knowl-
edge, this case report is the first of an erythema nodosum
induced by methimazole.
2. Case
A 64-year-old female patient was admitted to our outpatient
clinic with the complaints of multiple erythematous, painful,
nodules on both of the legs for fifteen days (Fig. 1). Labora-
tory examination revealed normal hepatic and renal functions.
Complete blood count showed mild neutrophilia. Skin biopsy.doi.org/
Figure 1 Multiple erythematous, nodules on both of the lower
legs.
Figure 2 Mixed type inflammatory cell infiltration and lympho-
cytic vasculitis in dermis. HE, 40.
Figure 3 There is an inflammation compatible with septal
panniculitis in subcutaneous fat tissue. HE, 200.
Figure 4 The appearance of the legs after healing.
2 S. Emre et al.was performed from erythematous nodules. Histopathological
examination revealed spongiosis in epidermis, mixed type
inflammatory cell infiltration and lymphocytic vasculitis in
dermis and inflammation consistent with septal panniculitis
at the subcutaneous tissue (Figs. 2 and 3). She was diagnosed
as EN based on physical and histopathological examinations.
Chest radiography, erythrocyte sedimentation rate, urinalysis,
antinuclear antibody, and serum ACE levels were normal.
Mantoux test, serology for hepatitis and laboratory tests for
other infectious agents were negative. She had essential hyper-
tension for 5 years and was using perindopril 5 mg/day and
indapamide 1.25 mg/day. Methimazole 20 mg per day was also
started for hyperthyroidism associated with Graves’ disease, a
month ago. Her serum free T4 and free T3 levels were in nor-
mal limits and TSH was 0.05 mIU/mL (0.27–4.2 mIU/mL) at
that time. On the other hand, indomethacin 75 mg/day, and
topical corticosteroid creams were prescribed for the treatmentPlease cite this article in press as: Emre, S. et al., A case of severe erythema nodosum i
10.1016/j.jsps.2016.11.003of erythema nodosum. Empirical amoxicillin/clavulanic acid
(875 mg/125 mg twice daily peroral) was started against possi-
ble streptococcal infections before laboratory tests resulted.
Elevation and wet dressing were also recommended at the
same time. Since laboratory results did not show evidence of
any infection, the antibiotic therapy was stopped after three
days. We noticed that her complaints were increased at the sec-
ond follow-up appointment. When we deepened the history of
the patient we discovered that her complaints were started fif-
teen days after the beginning of methimazole treatment. There-
fore methimazole was stopped and the lesions improved in one
week (Fig. 4). Propylthiouracil was started instead of methima-
zole and after that time she has not reported any side effects or
complaints about this drug during the medication for a year.
The consent of the patient was received for this report.nduced by methimazole. Saudi Pharmaceutical Journal (2016), http://dx.doi.org/
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Anti-thyroid drugs (ATDs) that are the members of the thioa-
mide group include methimazole, carbimazole and propylth-
iouracil have been used in the treatment of the
hyperthyroidism for approximately 60 years. Methimazole is
active metabolite of carbimazole (Taylor and Vaidya, 2012).
The most common side effects of ATDs are skin rash, low
grade liver dysfunction, granulocytopenia and arthralgia.
Myeloperoxidase antineutrophil cytoplasmic antibody
(ANCA) related vasculitis, agranulocytosis and severe hepato-
toxicity are rare but serious complications of ATDs (Yang
et al., 2015). EN is an immune associated non-specific cuta-
neous reaction that develops as a response to a specific stimuli.
It has been presumed to be a hypersensitivity reaction. Hyper-
sensitivity reactions due to medications have been recognized
as a cause of 3–10% of erythema nodosum cases (Schwartz
and Nervi, 2007). Case reports of EN associated with the
anti-thyroid drugs are quite rarely reported in the literature
even if there is a common use of anti-thyroid drugs.
Up to date there are only a few anecdotal cases about these
anti-thyroid drugs and EN. Two case reports of EN induced
by propylthiouracil have been reported (Keren et al., 1985;
Wan et al., 2012). In the EN case induced by propylthiouracil
that was reported by Wan et al., ANCA positivity was also
accompanied (Wan et al., 2012). The third case of EN induced
by ATDs was due to carbimazole. EN, acute pancreatitis and
hepatic cholestasis were reported in a 33 year-old female
patient using carbimazole. These side effects were observed
one month later from the beginning of the carbimazole treat-
ment in this patient (Marazuela et al., 2002). Different from
the other cases, our patient was the first case of EN that was
observed after the usage of methimazole. In our patient lesions
continued to develop by increasing even if there is an adequate
treatment for EN in a period of one month and lesions had dis-
appeared by improving fast in one week after the cessation of
the treatment. We could not find any other etiologic reasons
for EN. Streptococcal infections are one of the most common
causes of EN (Chowaniec et al., 2016; Starba et al., 2016). We
had prescribed empirical antibiotic therapy against possible
streptococcal infections, by the time the laboratory tests
resulted. But streptococcal infection was not found on labora-
tory examinations and we stopped antibiotic therapy. There-
fore we thought that these EN lesions were induced by
methimazole. The EN lesions were localized on the lower legs
typically. While the lesions are present, the methimazole treat-Please cite this article in press as: Emre, S. et al., A case of severe erythema nodosum i
10.1016/j.jsps.2016.11.003ment was stopped and propylthiouracil treatment was started.
There was no recurrence in a period of 1 year follow-up during
propylthiouracil treatment. Since these lesions appeared
2 weeks after the beginning of the methimazole, we think that
these EN lesions are idiosyncratic hypersensitivity reaction.
Sulfonamides are well-known causes of EN. Marazuela et al.
(2002) suggested that the sulphydryl groups that are the com-
ponents of thioamides can cause hypersensitivity reaction and
EN. However, in our case propylthiouracil did not induce EN
which was also a member of thioamide group. Probably, in our
case methimazole caused immune–mediated reaction by
another different way. Therefore we should keep methimazole
induced EN in mind in the patients that have EN like lesions
that the etiologic factors cannot be illuminated during methi-
mazole treatment.
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